U.S. label preparations
Medication directory
166 results | Page 6 of 6
- Ustekinumab-aauz (Otulfi)Dilution required
- Ustekinumab-aekn (Selarsdi)Dilution required
- Ustekinumab-auub (Wezlana)Dilution required
- Ustekinumab-hmny (Starjemza)Dilution required
- Ustekinumab-kfce (Yesintek)Dilution required
- Ustekinumab-srlf (Imuldosa)Dilution required
- Ustekinumab-stba (Steqeyma)Dilution required
- Ustekinumab-ttwe (Pyzchiva)Dilution required
- VancomycinAntibacterialHistorical article / Reconstitution and dilution / 1 reviewed statements
- VasopressinCardiovascular and vasoactiveHistorical article / No admixture required
- VedolizumabBiologics and immunotherapyHistorical article / Reconstitution and dilution / 3 reviewed statements
- Veligrotug-vvze (Lumvoa)Dilution required
- Velmanase alfa-tycv (Lamzede)Reconstitution only
- Zanidatamab-hrii (Ziihera)Reconstitution and dilution
- Zenocutuzumab-zbco (Bizengri)Dilution required
- Zolbetuximab-clzb (Vyloy)Reconstitution and dilution
Official label links, archived source snapshots, and reviewed local statements represent different levels of evidence work. Only statements with the required source mapping appear as reviewed local content.
See actual clinical evidence coverage